Oncology Historical Balance Sheet

TOIIW Stock

USD 0.02 0 26.85%

Trend analysis of The Oncology Institute balance sheet accounts such as Total Stockholder Equity of 78.4 M, Property Plant And Equipment Net of 42.1 M, Net Debt of 90.5 M or Accounts Payable of 13.4 M provides information on Oncology Institute's total assets, liabilities, and equity, which is the actual value of The Oncology Institute to its prevalent stockholders. By breaking down trends over time using Oncology Institute balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining The Oncology Institute latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether The Oncology Institute is a good buy for the upcoming year.

Oncology Institute Inventory

8.28 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in The Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

About Oncology Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of The Oncology Institute at a specified time, usually calculated after every quarter, six months, or one year. Oncology Institute Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Oncology Institute and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Oncology currently owns. An asset can also be divided into two categories, current and non-current.

Oncology Institute Balance Sheet Chart

At this time, Oncology Institute's Total Stockholder Equity is fairly stable compared to the past year. Property Plant And Equipment Net is likely to climb to about 42.1 M in 2024, whereas Total Assets are likely to drop slightly above 176.4 M in 2024.

Common Stock Shares Outstanding Total Assets Other Current Liab Total Current Liabilities Net Debt Property Plant And Equipment Gross

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Oncology Institute assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in The Oncology Institute books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Oncology Institute balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of The Oncology Institute are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most accounts from Oncology Institute's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into The Oncology Institute current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in The Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.At this time, Oncology Institute's Total Stockholder Equity is fairly stable compared to the past year. Property Plant And Equipment Net is likely to climb to about 42.1 M in 2024, whereas Total Assets are likely to drop slightly above 176.4 M in 2024.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	13.3M	13.3M	13.5M	11.2M
Total Assets	203.4M	263.7M	209.2M	176.4M

Other Current Liab Total Assets

Oncology Institute balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital
Common Stock Shares Outstanding		0.84	0.85	0.88	0.68	0.74	0.4	-0.78	0.69	0.53	0.7	0.8	0.79	0.8	0.31	0.83	0.76	0.78	0.89	0.86	0.78	0.72	0.82	-0.67	0.25	0.79
Total Assets	0.84		0.98	0.86	0.9	0.82	0.4	-0.78	0.65	0.64	0.86	0.91	0.94	0.91	0.45	0.98	0.86	0.91	0.96	0.97	0.98	0.79	0.97	-0.91	0.35	0.96
Other Current Liab	0.85	0.98		0.92	0.84	0.8	0.33	-0.85	0.78	0.73	0.75	0.94	0.97	0.89	0.4	0.97	0.88	0.96	0.98	0.98	0.94	0.79	0.99	-0.9	0.43	0.98
Total Current Liabilities	0.88	0.86	0.92		0.63	0.78	0.38	-0.91	0.87	0.63	0.63	0.89	0.86	0.84	0.23	0.88	0.85	0.87	0.97	0.92	0.77	0.78	0.89	-0.68	0.3	0.85
Total Stockholder Equity	0.68	0.9	0.84	0.63		0.59	0.18	-0.5	0.43	0.64	0.85	0.66	0.84	0.68	0.75	0.79	0.57	0.81	0.77	0.78	0.89	0.55	0.84	-0.85	0.5	0.86
Property Plant And Equipment Net	0.74	0.82	0.8	0.78	0.59		0.79	-0.9	0.53	0.29	0.76	0.87	0.68	0.93	-0.07	0.88	0.91	0.64	0.82	0.88	0.83	1.0	0.76	-0.8	-0.16	0.74
Net Debt	0.4	0.4	0.33	0.38	0.18	0.79		-0.55	0.0	-0.36	0.63	0.48	0.12	0.69	-0.41	0.5	0.61	0.06	0.38	0.49	0.47	0.79	0.25	-0.33	-0.71	0.21
Retained Earnings	-0.78	-0.78	-0.85	-0.91	-0.5	-0.9	-0.55		-0.83	-0.52	-0.54	-0.9	-0.77	-0.85	0.06	-0.85	-0.9	-0.77	-0.88	-0.87	-0.72	-0.92	-0.82	0.74	-0.08	-0.79
Accounts Payable	0.69	0.65	0.78	0.87	0.43	0.53	0.0	-0.83		0.83	0.22	0.74	0.82	0.55	0.19	0.67	0.66	0.86	0.81	0.71	0.52	0.55	0.8	-0.58	0.55	0.76
Cash	0.53	0.64	0.73	0.63	0.64	0.29	-0.36	-0.52	0.83		0.21	0.58	0.86	0.35	0.59	0.57	0.43	0.89	0.67	0.59	0.54	0.28	0.79	-0.67	0.89	0.8
Non Current Assets Total	0.7	0.86	0.75	0.63	0.85	0.76	0.63	-0.54	0.22	0.21		0.68	0.63	0.84	0.42	0.81	0.68	0.58	0.74	0.8	0.9	0.71	0.7	-0.71	-0.01	0.7
Non Currrent Assets Other	0.8	0.91	0.94	0.89	0.66	0.87	0.48	-0.9	0.74	0.58	0.68		0.89	0.95	0.1	0.98	0.98	0.86	0.94	0.98	0.9	0.87	0.94	-0.86	0.21	0.92
Cash And Short Term Investments	0.79	0.94	0.97	0.86	0.84	0.68	0.12	-0.77	0.82	0.86	0.63	0.89		0.77	0.49	0.91	0.79	0.99	0.93	0.91	0.88	0.66	0.99	-0.9	0.61	0.99
Net Receivables	0.8	0.91	0.89	0.84	0.68	0.93	0.69	-0.85	0.55	0.35	0.84	0.95	0.77		0.08	0.97	0.97	0.73	0.91	0.96	0.93	0.91	0.85	-0.81	-0.01	0.83
Good Will	0.31	0.45	0.4	0.23	0.75	-0.07	-0.41	0.06	0.19	0.59	0.42	0.1	0.49	0.08		0.25	-0.05	0.51	0.33	0.25	0.4	-0.12	0.42	-0.35	0.76	0.45
Non Current Liabilities Total	0.83	0.98	0.97	0.88	0.79	0.88	0.5	-0.85	0.67	0.57	0.81	0.98	0.91	0.97	0.25		0.95	0.87	0.96	1.0	0.97	0.86	0.95	-0.89	0.23	0.94
Inventory	0.76	0.86	0.88	0.85	0.57	0.91	0.61	-0.9	0.66	0.43	0.68	0.98	0.79	0.97	-0.05	0.95		0.76	0.9	0.95	0.87	0.9	0.86	-0.81	0.04	0.84
Other Current Assets	0.78	0.91	0.96	0.87	0.81	0.64	0.06	-0.77	0.86	0.89	0.58	0.86	0.99	0.73	0.51	0.87	0.76		0.93	0.89	0.83	0.63	0.98	-0.86	0.65	0.97
Other Stockholder Equity	0.89	0.96	0.98	0.97	0.77	0.82	0.38	-0.88	0.81	0.67	0.74	0.94	0.93	0.91	0.33	0.96	0.9	0.93		0.98	0.9	0.8	0.96	-0.82	0.35	0.94
Total Liab	0.86	0.97	0.98	0.92	0.78	0.88	0.49	-0.87	0.71	0.59	0.8	0.98	0.91	0.96	0.25	1.0	0.95	0.89	0.98		0.95	0.86	0.96	-0.87	0.25	0.94
Net Invested Capital	0.78	0.98	0.94	0.77	0.89	0.83	0.47	-0.72	0.52	0.54	0.9	0.9	0.88	0.93	0.4	0.97	0.87	0.83	0.9	0.95		0.79	0.92	-0.92	0.26	0.93
Property Plant And Equipment Gross	0.72	0.79	0.79	0.78	0.55	1.0	0.79	-0.92	0.55	0.28	0.71	0.87	0.66	0.91	-0.12	0.86	0.9	0.63	0.8	0.86	0.79		0.74	-0.78	-0.17	0.72
Total Current Assets	0.82	0.97	0.99	0.89	0.84	0.76	0.25	-0.82	0.8	0.79	0.7	0.94	0.99	0.85	0.42	0.95	0.86	0.98	0.96	0.96	0.92	0.74		-0.91	0.5	1.0
Capital Stock	-0.67	-0.91	-0.9	-0.68	-0.85	-0.8	-0.33	0.74	-0.58	-0.67	-0.71	-0.86	-0.9	-0.81	-0.35	-0.89	-0.81	-0.86	-0.82	-0.87	-0.92	-0.78	-0.91		-0.36	-0.94
Non Current Liabilities Other	0.25	0.35	0.43	0.3	0.5	-0.16	-0.71	-0.08	0.55	0.89	-0.01	0.21	0.61	-0.01	0.76	0.23	0.04	0.65	0.35	0.25	0.26	-0.17	0.5	-0.36		0.52
Net Working Capital	0.79	0.96	0.98	0.85	0.86	0.74	0.21	-0.79	0.76	0.8	0.7	0.92	0.99	0.83	0.45	0.94	0.84	0.97	0.94	0.94	0.93	0.72	1.0	-0.94	0.52

Click cells to compare fundamentals

Oncology Institute Account Relationship Matchups

Oncology Institute balance sheet Accounts

		2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding		64.4M	59.1M	66.2M	80.6M	73.7M	68.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Oncology Historical Balance Sheet

Oncology Institute Inventory

8.28 Million

About Oncology Balance Sheet Analysis

Oncology Institute Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Total Current Liabilities

Net Debt

Oncology Institute balance sheet Correlations

Oncology Institute Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Oncology Institute balance sheet Accounts

Also Currently Popular

Additional Tools for Oncology Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Liab	+ 1.0	Non Current Liabilities Total
Net Working Capital	+ 1.0	Total Current Assets
Total Current Assets	+ 0.99	Other Current Liab
Other Current Assets	+ 0.99	Cash And Short Term Investments
Total Current Assets	+ 0.99	Cash And Short Term Investments

Net Working Capital	- 0.94	Capital Stock
Capital Stock	- 0.92	Net Invested Capital
Property Plant And Equipment Gross	- 0.92	Retained Earnings
Capital Stock	- 0.91	Total Current Assets
Retained Earnings	- 0.91	Total Current Liabilities
Capital Stock	- 0.91	Total Assets